Wolverine Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-48,700
Closed -$361K – 1816
2026
Q1
$361K Buy
48,700
+10,500
+27% +$110K ﹤0.01% 993
2025
Q4
$449K Buy
+38,200
New +$412K ﹤0.01% 953
2025
Q1
– Sell
-4,300
Closed -$70.9K – 1702
2024
Q4
$70.9K Sell
4,300
-4,400
-51% -$68.3K ﹤0.01% 1152
2024
Q3
$128K Buy
+8,700
New +$136K ﹤0.01% 1082
2020
Q4
– Sell
-500
Closed -$18K – 1806
2020
Q3
$18K Hold
500
– – ﹤0.01% 1415
2020
Q2
$15K Buy
+500
New +$13.9K ﹤0.01% 1394

Other funds holding NEO

Wolverine Asset Management's NEO Position: Q2 2026 in Review

Wolverine Asset Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 23,343 shares — an estimated $173K sold.

Wolverine Asset Management first reported a position in NEO in Q1 2022 and held it in 3 quarters. The position peaked at $1.73M in Q1 2022. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Wolverine Asset Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 23,343 NeoGenomics shares in Q2 2026, an estimated $173K.
  • Wolverine Asset Management first reported a position in NeoGenomics in Q1 2022 and held it in 3 quarters.
  • Wolverine Asset Management's NeoGenomics position peaked at $1.73M in Q1 2022.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.